基于拓增强图形神经网络的药物目标亲和力预测
Hengliang Guo1,2, Congxiang Zhang2, Jiandong Shang1,2
1National Supercomputing Center in Zhengzhou, Zhengzhou University, Zhengzhou 450001, China.
Journal of chemical information and modeling
|March 31, 2025
概括
这项研究引入了一个新的图形神经网络 (GNN),它使用蛋白质口袋数据进行更准确的药物向亲和力 (DTA) 预测,提高药物发现效率.
科学领域:
- 计算化学是一种计算化学.
- 生物信息学是一种生物信息学.
- 机器学习 机器学习
背景情况:
- 图形神经网络 (GNN) 通过分析分子结构,在药物向亲和力 (DTA) 预测方面表现出色.
- 当前的GNN模型往往忽略了关键的蛋白质腔信息,限制了预测准确度.
- 药物开发需要有效和准确的方法来预测药物和蛋白质标之间的相互作用.
研究的目的:
- 开发一种新的拓增强的GNN,用于改进DTA预测.
- 将蛋白质口袋数据集成到GNN中,以增强特征表示.
- 优化GNN培训和消息传递,以提高性能.
主要方法:
- 设计了一个全新的拓增强图形神经网络 (GNN) 架构.
- 蛋白质口袋结构数据被纳入了GNN模型.
- 训练和消息传递策略被优化为特征学习.
主要成果:
- 拟议的GNN模型在DTA预测中表现出卓越的性能.
- 整合蛋白质口袋数据显著提高了预测准确度.
- 该模型有效地捕获了复杂的药物向相互作用.
结论:
- 拓增强的GNN为DTA预测提供了一个强大的方法.
- 纳入蛋白质腔信息对于准确的药物向相互作用建模至关重要.
- 这种方法可以通过提高预测效率来加速药物发现.
更多相关视频
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
3.2K
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
1.1K
相关概念视频
Protein-protein Interfaces
12.6K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.6K
Protein Networks
3.7K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.7K
Drug Discovery: Overview
10.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
Targets for Drug Action: Overview
9.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.4K
Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129
